Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Profile Treatment Approach Name | IDH2 Inhibitor |
Profile Name | IDH2 act mut |
Drug Class | IDH2 Inhibitor 5 |
Therapy |
PubMed Id | Reference Title | Details |
---|---|---|
(28193778) | AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations. | Full reference... |
(28588020) | Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia. | Full reference... |